Philadelphia, PA5 Active Studies

Liver Disease Clinical Trials in Philadelphia, PA

Find 5 actively recruiting liver disease clinical trials in Philadelphia, PA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
8,184
Enrolling

Recruiting Liver Disease Studies in Philadelphia

About Liver Disease Clinical Trials in Philadelphia

Chronic liver disease encompasses conditions that damage the liver over time, including cirrhosis, hepatitis, and fatty liver disease. The liver plays a crucial role in digestion, metabolism, and detoxification. Treatment depends on the cause and may include medications, lifestyle changes, or liver transplant.

There are currently 5 liver disease clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 8,184 participants. Research is being sponsored by Duke University, European Foundation for Study of Chronic Liver Failure, Indiana University and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Liver Disease Clinical Trials in Philadelphia — FAQ

Are there liver disease clinical trials in Philadelphia?

Yes, there are 5 liver disease clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Philadelphia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.

Are clinical trials in Philadelphia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.

What liver disease treatments are being tested?

The 5 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for liver disease.

Data updated July 13, 2026 from ClinicalTrials.gov